Pages that link to "Q41721035"
Jump to navigation
Jump to search
The following pages link to Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. (Q41721035):
Displaying 50 items.
- Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin (Q22008776) (← links)
- Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family (Q24314750) (← links)
- Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells (Q24337943) (← links)
- Identification of heregulin, a specific activator of p185erbB2 (Q24338146) (← links)
- Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma (Q24561375) (← links)
- Humanization of an anti-p185HER2 antibody for human cancer therapy (Q24561842) (← links)
- The ltk gene encodes a novel receptor-type protein tyrosine kinase (Q24564727) (← links)
- William L. McGuire Memorial Symposium. The role of erbB2 signal transduction pathways in human breast cancer (Q28237089) (← links)
- The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor (Q28295368) (← links)
- Heregulin induces tyrosine phosphorylation of HER4/p180erbB4 (Q28589513) (← links)
- The cellular response to neuregulins is governed by complex interactions of the erbB receptor family (Q28609130) (← links)
- Dominant-negative mutants of Grb2 induced reversal of the transformed phenotypes caused by the point mutation-activated rat HER-2/Neu (Q28678768) (← links)
- The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells (Q28678816) (← links)
- Cellular effects of HER3-specific affibody molecules (Q28727774) (← links)
- Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor. (Q30988881) (← links)
- p185neu is expressed in yolk sac during rat postimplantation development (Q33879687) (← links)
- Bivalence of EGF-like ligands drives the ErbB signaling network (Q33887274) (← links)
- Human breast cancer cell lines as models of growth regulation and disease progression (Q33962733) (← links)
- Adenovirus-directed expression of Q227L-G alpha(s) inhibits growth of established tumors of later-stage human breast cancer cells in athymic mice (Q34010590) (← links)
- Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships (Q34045509) (← links)
- The significance of immunohistochemistry in the diagnosis and therapy of neoplasms (Q34602545) (← links)
- Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation (Q34686462) (← links)
- Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation (Q35069004) (← links)
- Hormone receptors in malignancy (Q35228457) (← links)
- Overexpression of the p185erB-2 tyrosine kinase growth factor receptor: control or chaos (Q35252008) (← links)
- Clinical significance of erbB-2 (HER-2/neu) protein (Q35269163) (← links)
- Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene (Q35621568) (← links)
- Growth regulation of ovarian cancer. (Q35683646) (← links)
- Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines (Q35830913) (← links)
- c-fos oncogene underexpression in salivary gland tumors as measured by in situ hybridization. (Q35832516) (← links)
- erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification (Q36080272) (← links)
- Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells (Q36136193) (← links)
- Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling (Q36200357) (← links)
- Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer (Q36245510) (← links)
- Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research (Q36516942) (← links)
- Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic (Q36517425) (← links)
- Diagnostic utility of oncogenes and their products in human cancer (Q36536905) (← links)
- Heregulin, a new interactor of the telosome/shelterin complex in human telomeres. (Q36545398) (← links)
- Heregulin, a new regulator of telomere length in human cells (Q36545401) (← links)
- Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha (Q36565186) (← links)
- Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status (Q36623220) (← links)
- Structural and functional aspects of the multiplicity of Neu differentiation factors (Q36648114) (← links)
- 17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product (Q36674311) (← links)
- A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells (Q36678230) (← links)
- Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells (Q36684680) (← links)
- Fibroblasts are critical determinants in prostatic cancer growth and dissemination (Q36708576) (← links)
- Negative autoregulation of the neu gene is mediated by a novel enhancer (Q36817452) (← links)
- The mammary gland (Q36844559) (← links)
- Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses (Q36893092) (← links)
- Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene (Q36961265) (← links)